1
|
Héraud C, Goufak D, Ando K, Leroy K, Suain V, Yilmaz Z, De Decker R, Authelet M, Laporte V, Octave JN, Brion JP. Increased misfolding and truncation of tau in APP/PS1/tau transgenic mice compared to mutant tau mice. Neurobiol Dis 2013; 62:100-12. [PMID: 24076100 DOI: 10.1016/j.nbd.2013.09.010] [Citation(s) in RCA: 47] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2013] [Revised: 08/16/2013] [Accepted: 09/17/2013] [Indexed: 02/01/2023] Open
Abstract
Neurofibrillary degeneration in transgenic models of tauopathies has been observed to be enhanced when these models are crossed with transgenic models developing an Aβ pathology. The mechanisms leading to this enhanced tau pathology are not well understood. We have performed a detailed analysis of tau misprocessing in a new transgenic mouse model combining APP, PS1 and tau mutations (5xFAD×Tg30 mice) by comparison with littermates expressing only a FTD mutant tau (Tg30 mice). These 5xFAD×Tg30 mice showed a more severe deficient motor phenotype than Tg30 mice and developed with age a dramatically accelerated NFT load in the brain compared to Tg30 mice. Insoluble tau in 5xFAD×Tg30 mice compared to insoluble tau in Tg30 mice showed increased phosphorylation, enhanced misfolding and truncation changes mimicking more closely the post-translational changes characteristic of PHF-tau in Alzheimer's disease. Endogenous wild-type mouse tau was recruited at much higher levels in insoluble tau in 5xFAD×Tg30 than in Tg30 mice. Extracellular amyloid load, Aβ40 and Aβ42, β-CTFs and β-CTF phosphorylation levels were lower in 5xFAD×Tg30 mice than in 5xFAD mice. Despite this reduction of Aβ, a significant hippocampal neuronal loss was observed in 5xFAD×Tg30 but not in 5xFAD mice indicating its closer association with increased tau pathology. This 5xFAD×Tg30 model thus mimics more faithfully tau pathology and neuronal loss observed in AD and suggests that additional post-translational changes in tau and self-recruitment of endogenous tau drive the enhanced tau pathology developing in the presence of Aβ pathology.
Collapse
Affiliation(s)
- Céline Héraud
- Université Libre de Bruxelles (ULB), Laboratory of Histology, Neuroanatomy and Neuropathology, ULB Neuroscience Institute, B-1070 Brussels, Belgium
| | - Doris Goufak
- Université Libre de Bruxelles (ULB), Laboratory of Histology, Neuroanatomy and Neuropathology, ULB Neuroscience Institute, B-1070 Brussels, Belgium
| | - Kunie Ando
- Université Libre de Bruxelles (ULB), Laboratory of Histology, Neuroanatomy and Neuropathology, ULB Neuroscience Institute, B-1070 Brussels, Belgium
| | - Karelle Leroy
- Université Libre de Bruxelles (ULB), Laboratory of Histology, Neuroanatomy and Neuropathology, ULB Neuroscience Institute, B-1070 Brussels, Belgium
| | - Valérie Suain
- Université Libre de Bruxelles (ULB), Laboratory of Histology, Neuroanatomy and Neuropathology, ULB Neuroscience Institute, B-1070 Brussels, Belgium
| | - Zehra Yilmaz
- Université Libre de Bruxelles (ULB), Laboratory of Histology, Neuroanatomy and Neuropathology, ULB Neuroscience Institute, B-1070 Brussels, Belgium
| | - Robert De Decker
- Université Libre de Bruxelles (ULB), Laboratory of Histology, Neuroanatomy and Neuropathology, ULB Neuroscience Institute, B-1070 Brussels, Belgium
| | - Michèle Authelet
- Université Libre de Bruxelles (ULB), Laboratory of Histology, Neuroanatomy and Neuropathology, ULB Neuroscience Institute, B-1070 Brussels, Belgium
| | - Vincent Laporte
- Université Catholique de Louvain (UCL), Institute of Neuroscience, B-1200 Brussels, Belgium
| | - Jean-Noël Octave
- Université Catholique de Louvain (UCL), Institute of Neuroscience, B-1200 Brussels, Belgium
| | - Jean-Pierre Brion
- Université Libre de Bruxelles (ULB), Laboratory of Histology, Neuroanatomy and Neuropathology, ULB Neuroscience Institute, B-1070 Brussels, Belgium.
| |
Collapse
|
2
|
Leroy K, Ando K, Laporte V, Dedecker R, Suain V, Authelet M, Héraud C, Pierrot N, Yilmaz Z, Octave JN, Brion JP. Lack of tau proteins rescues neuronal cell death and decreases amyloidogenic processing of APP in APP/PS1 mice. THE AMERICAN JOURNAL OF PATHOLOGY 2012; 181:1928-40. [PMID: 23026200 DOI: 10.1016/j.ajpath.2012.08.012] [Citation(s) in RCA: 97] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/29/2012] [Revised: 07/04/2012] [Accepted: 08/09/2012] [Indexed: 12/12/2022]
Abstract
Lack of tau expression has been reported to protect against excitotoxicity and to prevent memory deficits in mice expressing mutant amyloid precursor protein (APP) identified in familial Alzheimer disease. In APP mice, mutant presenilin 1 (PS1) enhances generation of Aβ42 and inhibits cell survival pathways. It is unknown whether the deficient phenotype induced by concomitant expression of mutant PS1 is rescued by absence of tau. In this study, we have analyzed the effect of tau deletion in mice expressing mutant APP and PS1. Although APP/PS1/tau(+/+) mice had a reduced survival, developed spatial memory deficits at 6 months and motor impairments at 12 months, these deficits were rescued in APP/PS1/tau(-/-) mice. Neuronal loss and synaptic loss in APP/PS1/tau(+/+) mice were rescued in the APP/PS1/tau(-/-) mice. The amyloid plaque burden was decreased by roughly 50% in the cortex and the spinal cord of the APP/PS1/tau(-/-) mice. The levels of soluble and insoluble Aβ40 and Aβ42, and the Aβ42/Aβ40 ratio were reduced in APP/PS1/tau(-/-) mice. Levels of phosphorylated APP, of β-C-terminal fragments (CTFs), and of β-secretase 1 (BACE1) were also reduced, suggesting that β-secretase cleavage of APP was reduced in APP/PS1/tau(-/-) mice. Our results indicate that tau deletion had a protective effect against amyloid induced toxicity even in the presence of mutant PS1 and reduced the production of Aβ.
Collapse
Affiliation(s)
- Karelle Leroy
- Laboratory of Histology, Neuroanatomy, and Neuropathology, Université Libre de Bruxelles, 808 Route de Lennik, Brussels, Belgium
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Macq AF, Czech C, Essalmani R, Brion JP, Maron A, Mercken L, Pradier L, Octave JN. The long term adenoviral expression of the human amyloid precursor protein shows different secretase activities in rat cortical neurons and astrocytes. J Biol Chem 1998; 273:28931-6. [PMID: 9786896 DOI: 10.1074/jbc.273.44.28931] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Recombinant adenoviruses were used for the expression of human amyloid precursor protein (APP) of Alzheimer's disease in primary cultures of rat cortical neurons and astrocytes. The catabolic pathways of human APP were studied 3 to 4 days after infection, when the equilibrium of APP production was reached. Although the expression of human wild type APP (WtAPP) by rat neurons induced the production of both extracellular and intraneuronal amyloid peptide (Abeta), Abeta was not detected in the culture medium of rat astrocytes producing human WtAPP. Because a low beta-secretase activity was previously reported in rodent astrocytes, we wondered whether modifications of the APP amino acid sequence at the beta-secretase clipping site would modify the astrocytic production of Abeta. Interestingly, rat astrocytes produced high amounts of Abeta after expression of human APP carrying a double amino acid substitution responsible for Alzheimer's disease in a large Swedish family (SwAPP). In both rat cortical neurons and astrocytes, the beta-secretase cleavage of the human SwAPP occurred very early in the secretion process in a cellular compartment in which a different sorting of SwAPP and WtAPP seems unlikely. These results suggest that human WtAPP and SwAPP could be processed by different beta-secretase activities.
Collapse
Affiliation(s)
- A F Macq
- Laboratory of Experimental Pharmacology, Université Catholique de Louvain, FARL 5410, 54 Avenue Hippocrate, B-1200 Brussels, Belgium
| | | | | | | | | | | | | | | |
Collapse
|